Feldman Firm PLLC

Andrew S. Feldman is the founder of Feldman Firm, PLLC.Mr. Feldman is a trial lawyer who defends professionals, corporations, health care providers, foreign nationals, health care marketers, and government contractors throughout the United States in government investigations from the investigative phase through trial. The Firm’s practice focuses heavily on representing health care providers, organizations, and marketers, ensnared in investigations or prosecutions involving violations of the health care fraud statute, violations of the Anti-Kickback Statute, the False Claims Act, or other health care fraud and abuse laws.

In addition, the Firm represents clients in global investigations involving violations of the Foreign Corrupt Practices Act (FCPA), violations of the International Emergency Economic Powers Act (IEEPA), and violations of rules promulgated by the Office of Foreign Asset Control (OFAC). One of the Firm’s matters garnered international attention relating to the government’s seizure of the Amadea vessel in Fiji.

Mr. Feldman represented a former treasurer of Venezuela and her husband at trial in a complex FCPA case. Mr. Feldman has defended clients throughout Latin America (Venezuela, Peru, Ecuador, Brazil) including clients in the FIFA and Odebrecht investigations. Mr. Feldman also regularly defends individuals as “targets” of government investigations related to bribery, money laundering, securities fraud, and tax evasion. Mr. Feldman's international practice also includes extensive experience defending clients in OFAC investigations and substantial experience representing clients in extradition proceedings involving Spain, Argentina, Thailand, and Japan.

Beyond this, the Firm represents companies and individuals in complex civil litigation focused on claims of fraud, theft, or misappropriation of assets.

Some of the Firm’s successes include:

-At trial, the Firm obtained a Rule 29 judgment of acquittal on the single major count – a wire fraud conspiracy alleging that the client participated in a fraudulent clinical trial related to asthma drugs sponsored by a multinational corporation.

-In a multi-month and multi-defendant Anti-Kickback trial involving genetic testing, the government was unable to convict the Firm’s client, a health care marketing and sales professional, and the court declared its first mistrial in eight years.

-Obtained a declination of prosecution for a government contractor who was the primary contractor for an infrastructure project on an Airforce Base.

-Avoided prosecution of client, an entrepreneur named as “co-conspirator” in the novel-size FCPA, and money laundering indictment related to FIFA and its affiliates.

-Obtained a declination of prosecution for CEO of a seafood company in a grand jury investigation initiated by FDA and National Oceanic and Atmospheric Administration (NOA) targeting violations of Food Drug and Cosmetic Act (FDCA), the Lacey Act, and violations of U.S. Customs laws.

-Obtained a declination of prosecution for a career sales and marketing professional in OIG-HHS and DCIS (OIG-DOD) grand jury investigation related to compounding pharmacy fraud, speaker fees, and violations of the Anti-Kickback Statute. The Government had initially designated the client as a “target.”

-Obtained a declination of prosecution for the target of securities fraud investigation involving fraudulent private securities offerings. The Client was the only one of seven defendants that was not indicted.

-The Firm prevailed in a bench trial against the Department of Justice Tax Division in an IRS summons proceeding involving the reporting of foreign assets and accounts.

-Obtained an ex parte temporary restraining order and an order of replevin permitting the client, a commercial truck and logistics company, to recover equipment valued at nearly One Million dollars which a former business partner had attempted to sell at auction as “abandoned property.”